Device Trial Radar · NCT03170349
The CLASP Study Edwards PASCAL TrAnScatheter Mitral Valve RePair System Study
Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
124
Actual
Start
Jun 27, 2017
Primary completion
Jul 30, 2020
Study completion May 27, 2025
Sponsor
- Lead sponsor
- Edwards LifesciencesPublic (EW)
- Sponsor type
- Industry
- First posted
- May 31, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the safety, performance and clinical outcomes of the Edwards PASCAL Transcatheter Mitral Valve Repair (TMVr) System.
Conditions
- Mitral Valve Regurgitation
Interventions
Mitral Valve RepairDevice
Minimal Invasive Transcatheter Mitral Valve Repair
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Major Adverse Events (MAE)Time frame: 30 days
- Device SuccessTime frame: Exit from the cardiac catheterization laboratory
- Number of Participants With Procedural SuccessTime frame: through discharge
1 more outcomes with a free account
Locations
17 sites in 7 countries. Site status is shown where the registry gives one.
Cedars-Sinai Medical Center
Los Angeles, California
University of Colorado Denver
Aurora, Colorado
NorthShore University HealthSystem
Evanston, Illinois
14 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.